Gene Therapy Also Effective in Younger Children With Inherited Blood Disorders

(MedPage Today) -- ORLANDO--The gene therapy exagamglogene autotemcel (exa-cel; Casgevy)--already approved for patients 12 years and older with transfusion-dependent beta-thalassemia (TDT) and sickle cell disease (SCD)--led to durable...